BackLineage Cell Therapeutics Overview

Lineage Cell Therapeutics Minority Interest

Track Lineage Cell Therapeutics's minority interest ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00
↓ 100.00% YoYΔ $1.27M vs prior year quarter

Peer trimmed avg / median

Loading

Lineage Cell Therapeutics Minority Interest History

Loading

Lineage Cell Therapeutics vs. peers: Minority Interest Comparison

Loading

Lineage Cell Therapeutics Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lineage Cell Therapeutics (LCTX) FAQ

As of the most recent data (June 2026), LCTX shows a minority interest of $0. That compares with $-1.3M in the prior-year period — up 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LCTX's minority interest is now $0 (was $-1.3M) — a 100.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Lineage Cell Therapeutics is outperforming or lagging.

Tracking LCTX's minority interest over time shows whether Lineage Cell Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $-1.3M in the prior-year period — up 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Lineage Cell Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $0) with ownership activity and broader fundamentals.

Lineage Cell Therapeutics's minority interest is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.